SELECT LANGUAGE BELOW

FDA Commissioner Says ‘No Plans’ to Pull Abortion Drugs

Food and Drug Administration (FDA) Commissioner Martin McCurry said Thursday that he “does not take any action” to limit the availability of mifepristone, the first drug used in a two-drug abortion regimen.

McCurry spoke on Thursday while speaking at the outlet Semafor World Economy Summit It has been reported.

” Speaking at the Semafor World Economy Summit, Makary said last month that he took a stronger stance on the issue and did not commit to certain actions, as he said he would ‘do a review of the data’ at a Senate confirmation hearing.

McCurry said the FDA could take action if data reveals drug risks.

“We have an ongoing dataset that appears in the FDA in Mifepristone,” he said. “Therefore, if the data suggests something or tells us there is an actual signal, we cannot promise not to act on that data.”

Republican Sen. Josh Hawley (R-MO) – his wife argued for the Supreme Court case against Mifepristone – responded to McCurry’s comments, calling it “very disappointing to say the least.”

“It’s not a good start from the FDA.”

At a confirmation hearing for HHS secretary Robert F. Kennedy Jr., Sen. James Lankford (R-OK) asked about him. We focused on the approach to Mifepristone and the FDA method Stop I need it All reports of complications related to abortion medication in 2016 are excluded from death. Rankford also pointed out how the FDA will be done under Biden Allowed Abortion medications are prescribed by TeleHealth and sent by mail. in risk.

Related – Report: Abortion drugs used in 63% of US abortions in 2023
Lankford asked:

My question for you is that the FDA actually works to give Americans transparency and say [mifepristone] Is there any difference from other medicines? [That] I’m not going to protect it just because [abortion] Is it political for some people? People should know about the side effects of this drug and need to be reported.

“The fact that patients and doctors should not report adverse events is opposed to everything we believe in this country,” Kennedy replied. “We need to know what the adverse events are. We need to understand the safety of all drugs. Mifepristone and all the other drugs. President Trump has made it clear that this is one of the things he hasn’t yet been in position, and that he wants to see safety issues in me.

In medication abortion, mifepristone block The effects of progesterone produced by the mother’s body feed on pregnancy. When progesterone is blocked, the mother’s uterus lining worsens, blocking it off by a baby with developed blood and nutrition, and then dies inside the mother’s uterus. The drug misoprostol (also known as Cytotec) causes contractions and bleeding to expel the baby from the mother’s uterus.

Particularly on medication abortion accounting According to the pro-aboration Guttmacher Institute, 63% of all abortions in the United States in 2023 increased from 53% in 2020.

Katherine Hamilton is a political reporter for Breitbart News. You can follow her on x @thekat_hamilton.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News